Lexeo Therapeutics (NASDAQ:LXEO) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Lexeo Therapeutics (NASDAQ:LXEO) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Lexeo Therapeutics (NASDAQ:LXEO - Get Free Report) announced its earnings results on Monday. The company reported ($0.78) EPS for the quarter, topping the consensus estimate of ($0.87) by $0.09.

Actelis Networks (NASDAQ:ASNS) Issues Earnings Results, Misses Estimates By $0.24 EPS

Actelis Networks (NASDAQ:ASNS – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.24), Zacks reports. The company had revenue of $3.00 million for the quarter, compared to the consensus estimate of $3.00 million. Actelis Networks had a negative return on equity of 752.62% and a negative net margin of 56.82%. Actelis Networks Sto…